911 related articles for article (PubMed ID: 28005427)
1. Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis.
Pardo A; Selman M
Ann Am Thorac Soc; 2016 Dec; 13 Suppl 5():S417-S421. PubMed ID: 28005427
[TBL] [Abstract][Full Text] [Related]
2. Cell-specific expression of runt-related transcription factor 2 contributes to pulmonary fibrosis.
Mümmler C; Burgy O; Hermann S; Mutze K; Günther A; Königshoff M
FASEB J; 2018 Feb; 32(2):703-716. PubMed ID: 28986417
[TBL] [Abstract][Full Text] [Related]
3. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
[TBL] [Abstract][Full Text] [Related]
4. The leading role of epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis.
Selman M; Pardo A
Cell Signal; 2020 Feb; 66():109482. PubMed ID: 31760172
[TBL] [Abstract][Full Text] [Related]
5. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
[TBL] [Abstract][Full Text] [Related]
6. Revealing the pathogenic and aging-related mechanisms of the enigmatic idiopathic pulmonary fibrosis. an integral model.
Selman M; Pardo A
Am J Respir Crit Care Med; 2014 May; 189(10):1161-72. PubMed ID: 24641682
[TBL] [Abstract][Full Text] [Related]
7. Sustained activation of toll-like receptor 9 induces an invasive phenotype in lung fibroblasts: possible implications in idiopathic pulmonary fibrosis.
Kirillov V; Siler JT; Ramadass M; Ge L; Davis J; Grant G; Nathan SD; Jarai G; Trujillo G
Am J Pathol; 2015 Apr; 185(4):943-57. PubMed ID: 25660181
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human PDGFR-β-positive pericytes from IPF and non-IPF lungs.
Wilson CL; Stephenson SE; Higuero JP; Feghali-Bostwick C; Hung CF; Schnapp LM
Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L991-L1002. PubMed ID: 30335500
[TBL] [Abstract][Full Text] [Related]
9. Mitochondria in the spotlight of aging and idiopathic pulmonary fibrosis.
Mora AL; Bueno M; Rojas M
J Clin Invest; 2017 Feb; 127(2):405-414. PubMed ID: 28145905
[TBL] [Abstract][Full Text] [Related]
10. Role of protease-activated receptor-2 in idiopathic pulmonary fibrosis.
Wygrecka M; Kwapiszewska G; Jablonska E; von Gerlach S; Henneke I; Zakrzewicz D; Guenther A; Preissner KT; Markart P
Am J Respir Crit Care Med; 2011 Jun; 183(12):1703-14. PubMed ID: 21471103
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Cellular Senescence Is Independent from Profibrotic Fibroblast-Deposited ECM.
Blokland KEC; Habibie H; Borghuis T; Teitsma GJ; Schuliga M; Melgert BN; Knight DA; Brandsma CA; Pouwels SD; Burgess JK
Cells; 2021 Jun; 10(7):. PubMed ID: 34209854
[TBL] [Abstract][Full Text] [Related]
12. Expression of WNT5A in Idiopathic Pulmonary Fibrosis and Its Control by TGF-β and WNT7B in Human Lung Fibroblasts.
Newman DR; Sills WS; Hanrahan K; Ziegler A; Tidd KM; Cook E; Sannes PL
J Histochem Cytochem; 2016 Feb; 64(2):99-111. PubMed ID: 26538547
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic Pulmonary Fibrosis: New and Emerging Treatment Options.
Hewitt RJ; Maher TM
Drugs Aging; 2019 Jun; 36(6):485-492. PubMed ID: 30864023
[TBL] [Abstract][Full Text] [Related]
14. Hsp90 regulation of fibroblast activation in pulmonary fibrosis.
Sontake V; Wang Y; Kasam RK; Sinner D; Reddy GB; Naren AP; McCormack FX; White ES; Jegga AG; Madala SK
JCI Insight; 2017 Feb; 2(4):e91454. PubMed ID: 28239659
[TBL] [Abstract][Full Text] [Related]
15. Senotherapeutics: Targeting senescence in idiopathic pulmonary fibrosis.
Merkt W; Bueno M; Mora AL; Lagares D
Semin Cell Dev Biol; 2020 May; 101():104-110. PubMed ID: 31879264
[TBL] [Abstract][Full Text] [Related]
16. Age-driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis.
Selman M; López-Otín C; Pardo A
Eur Respir J; 2016 Aug; 48(2):538-52. PubMed ID: 27390284
[TBL] [Abstract][Full Text] [Related]
17. Epithelium-dependent profibrotic milieu in the pathogenesis of idiopathic pulmonary fibrosis: current status and future directions.
Xu X; Dai H; Wang C
Clin Respir J; 2016 Mar; 10(2):133-41. PubMed ID: 25047066
[TBL] [Abstract][Full Text] [Related]
18. Klotho antagonizes pulmonary fibrosis through suppressing pulmonary fibroblasts activation, migration, and extracellular matrix production: a therapeutic implication for idiopathic pulmonary fibrosis.
Huang Q; Chen Y; Shen S; Wang Y; Liu L; Wu S; Xu W; Zhao W; Lin M; Wu J
Aging (Albany NY); 2020 Apr; 12(7):5812-5831. PubMed ID: 32244228
[TBL] [Abstract][Full Text] [Related]
19. Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis.
Korfei M; Skwarna S; Henneke I; MacKenzie B; Klymenko O; Saito S; Ruppert C; von der Beck D; Mahavadi P; Klepetko W; Bellusci S; Crestani B; Pullamsetti SS; Fink L; Seeger W; Krämer OH; Guenther A
Thorax; 2015 Nov; 70(11):1022-32. PubMed ID: 26359372
[TBL] [Abstract][Full Text] [Related]
20. Epithelial⁻Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis.
Salton F; Volpe MC; Confalonieri M
Medicina (Kaunas); 2019 Mar; 55(4):. PubMed ID: 30925805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
